Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia

Cardiovascular Pathology

Volumn 21, Issue 1, 2012, Pages 17-27

  Prêle, Cecilia M ^a   Reichelt, Melissa E ^b,c   Mutsaers, Steven E ^a,d   Davies, Marilyn ^a   Delbridge, Lea M ^c   Headrick, John P ^b   Rosenthal, Nadia ^e   Bogoyevitch, Marie A ^f   Grounds, Miranda D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d PathWest Laboratory Medicine   (United States)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Collagen; Fibrosis; Insulin like growth factor 1; Ischemia; Langendorff; Myocardial

Indexed keywords

COLLAGEN; DESMIN; HYDROXYPROLINE; LAMININ; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EX VIVO STUDY; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTION POTENTIALS; ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; COLLAGEN; CORONARY CIRCULATION; DESMIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEART RATE; INSULIN-LIKE GROWTH FACTOR I; LAMININ; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PERFUSION; RECOVERY OF FUNCTION;

EID: 82955216204     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2010.11.008     Document Type: Article

References (54)

1. Wang L, Ma W, Markovich R, Chen JW, and Wang PH Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I Circ Res 83 1998 516 522 (Pubitemid 28411053)
2. Wang L, Ma W, Markovich R, Lee WL, and Wang PH Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells Endocrinology 139 1998 1354 1360 (Pubitemid 28510157)
3. Conti E, Andreotti F, Sciahbasi A, Riccardi P, Marra G, Menini E, Ghirlanda G, and Maseri A Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction J Am Coll Cardiol 38 2001 26 32 (Pubitemid 32613824)
4. Reiss K, Cheng W, Ferber A, Kajstura J, Li P, Li B, Olivetti G, Homcy CJ, Baserga R, and Anversa P Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice Proc Natl Acad Sci U S A 93 1996 8630 8635 (Pubitemid 26269611)
5. Reiss K, Cheng W, Pierzchalski P, Kodali S, Li B, Wang S, Liu Y, and Anversa P Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle Exp Cell Res 235 1997 198 209 (Pubitemid 27381698)
6. Ren J Short-term administration of insulin-like growth factor I (IGF-1) does not induce myocardial IGF-1 resistance Growth Horm IGF Res 12 2002 162 168 (Pubitemid 35238090)
7. Ren J, Samson WK, and Sowers JR Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease J Mol Cell Cardiol 31 1999 2049 2061 (Pubitemid 29537604)
8. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, and Lefer AM Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion Proc Natl Acad Sci U S A 92 1995 8031 8035
9. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, and Ross J Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure J Clin Invest 95 1995 619 627
10. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, and Anversa P Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy J Clin Invest 100 1997 1991 1999 (Pubitemid 27459352)
11. Yang R, Bunting S, Gillett N, Clark R, and Jin H Growth hormone improves cardiac performance in experimental heart failure Circulation 92 1995 262 267
12. Donath MY, Sutsch G, Yan XW, Piva B, Brunner HP, Glatz Y, Zapf J, Follath F, Froesch ER, and Kiowski W Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure J Clin Endocrinol Metab 83 1998 3177 3183 (Pubitemid 28500953)
13. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, and Sacca L A preliminary study of growth hormone in the treatment of dilated cardiomyopathy N Engl J Med 334 1996 809 814 (Pubitemid 26099602)
14. Juul A, Scheike T, Davidsen M, Gyllenborg J, and Jorgensen T Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study Circulation 106 2002 939 944 (Pubitemid 34925327)
15. Lee WL, Chen JW, Ting CT, Lin SJ, and Wang PH Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling J Clin Endocrinol Metab 84 1999 1575 1581 (Pubitemid 30644257)
16. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, and Anker SD Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation J Am Coll Cardiol 32 1998 393 397 (Pubitemid 28396488)
17. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, and Wilson PW Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study Ann Intern Med 139 2003 642 648
18. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, and van Duijn CM A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction Diabetes 50 2001 637 642 (Pubitemid 32195230)
19. Yazdanpanah M, Rietveld I, Janssen JA, Njajou OT, Hofman A, Stijnen T, Pols HA, Lamberts SW, Witteman JC, and van Duijn CM An insulin-like growth factor-I promoter polymorphism is associated with increased mortality in subjects with myocardial infarction in an elderly Caucasian population Am J Cardiol 97 2006 1274 1276
20. Yazdanpanah M, Sayed-Tabatabaei FA, Janssen JA, Rietveld I, Hofman A, Stijnen T, Pols HA, Lamberts SW, Witteman JC, and van Duijn CM IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes Eur J Endocrinol 155 2006 751 756 (Pubitemid 44857500)
21. Shavlakadze T, Boswell JM, Burt DW, Asante EA, Tomas FM, Davies MJ, White JD, Grounds MD, and Goddard C Rskalpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: impact on regeneration, denervation and muscular dystrophy Growth Horm IGF Res 16 2006 157 173 (Pubitemid 44103479)
22. Matthews KG, Devlin GP, Stuart SP, Jensen JA, Doughty RN, Conaglen JV, and Bass JJ Intrapericardial IGF-I improves cardiac function in an ovine model of chronic heart failure Heart Lung Circ 14 2005 98 103 (Pubitemid 40895297)
23. Davani EY, Brumme Z, Singhera GK, Cote HC, Harrigan PR, and Dorscheid DR Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury Crit Care 7 2003 R176 R183
24. Chao W, Matsui T, Novikov MS, Tao J, Li L, Liu H, Ahn Y, and Rosenzweig A Strategic advantages of insulin-like growth factor-I expression for cardioprotection J Gene Med 5 2003 277 286 (Pubitemid 40310380)
25. Santini MP, Tsao L, Monassier L, Theodoropoulos C, Carter J, Lara-Pezzi E, Slonimsky E, Salimova E, Delafontaine P, Song YH, Bergmann M, Freund C, Suzuki K, and Rosenthal N Enhancing repair of the mammalian heart Circ Res 100 2007 1732 1740 (Pubitemid 46987865)
26. Palmen M, Daemen MJ, Bronsaer R, Dassen WR, Zandbergen HR, Kockx M, Smits JF, van der Zee R, and Doevendans PA Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice Cardiovasc Res 50 2001 516 524 (Pubitemid 32480245)
27. Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, Urbanek K, Nadal-Ginard B, Kajstura J, Anversa P, and Leri A Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression Circ Res 94 2004 514 524 (Pubitemid 38326287)
28. Shavlakadze T, Winn N, Rosenthal N, and Grounds MD Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle Growth Horm IGF Res 15 2005 4 18 (Pubitemid 40220850)
29. Hameed M, Orrell RW, Cobbold M, Goldspink G, and Harridge SD Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise J Physiol 547 2003 247 254 (Pubitemid 36285178)
30. Yang SY, and Goldspink G Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation FEBS Lett 522 2002 156 160 (Pubitemid 34722516)
31. Delaughter MC, Taffet GE, Fiorotto ML, Entman ML, and Schwartz RJ Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice FASEB J 13 1999 1923 1929 (Pubitemid 29517622)
32. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, and Eppenberger HM Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes Proc Natl Acad Sci U S A 91 1994 1686 1690 (Pubitemid 24080270)
33. Donath MY, Zierhut W, Gosteli-Peter MA, Hauri C, Froesch ER, and Zapf J Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat Eur J Endocrinol 139 1998 109 117 (Pubitemid 28351244)
34. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, and Marumo F Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes Circulation 87 1993 1715 1721 (Pubitemid 23133116)
35. Chew SL, Lavender P, Clark AJ, and Ross RJ An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide Endocrinology 136 1995 1939 1944
36. Reiss K, Kajstura J, Zhang X, Li P, Szoke E, Olivetti G, and Anversa P Acute myocardial infarction leads to upregulation of the IGF-1 autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes Exp Cell Res 213 1994 463 472 (Pubitemid 24259494)
37. Kotlyar AA, Vered Z, Goldberg I, Chouraqui P, Nas D, Fridman E, Chen-Levy Z, Fytlovich S, Sangiorgi G, Spagnoli LG, Orlandi A, Savion N, Eldar M, and Scheinowitz M Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine Heart 86 2001 693 700 (Pubitemid 33086893)
38. Infanger M, Faramarzi S, Grosse J, Kurth E, Ulbrich C, Bauer J, Wehland M, Kreutz R, Kossmehl P, Paul M, and Grimm D Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury Cardiovasc Pathol 16 2007 291 299 (Pubitemid 47375119)
39. Headrick JP, Peart J, Hack B, Flood A, and Matherne GP Functional properties and responses to ischaemia-reperfusion in Langendorff perfused mouse heart Exp Physiol 86 2001 703 716 (Pubitemid 33107643)
40. Headrick JP, Peart J, Hack B, Garnham B, and Matherne GP 5′-Adenosine monophosphate and adenosine metabolism, and adenosine responses in mouse, rat and guinea pig heart Comp Biochem Physiol A Mol Integr Physiol 130 2001 615 631 (Pubitemid 33016660)
41. Peart J, and Headrick JP Intrinsic A(1) adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts Am J Physiol Heart Circ Physiol 279 2000 H2166 H2175
42. Peart J, Willems L, and Headrick JP Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine Am J Physiol Heart Circ Physiol 284 2003 H519 H527
43. Reichelt ME, Willems L, Hack BA, Peart JN, and Headrick JP Cardiac and coronary function in the Langendorff-perfused mouse heart model Exp Physiol 94 2009 54 70
44. Mutsaers SE, Foster ML, Chambers RC, Laurent GJ, and McAnulty RJ Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats Am J Respir Cell Mol Biol 18 1998 611 619 (Pubitemid 128354133)
45. Mahdavi V, Chambers AP, and Nadal-Ginard B Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem Proc Natl Acad Sci U S A 81 1984 2626 2630 (Pubitemid 14109312)
46. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, and Robbins J Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice J Biol Chem 266 1991 24613 24620 (Pubitemid 21908985)
47. Horio T, Maki T, Kishimoto I, Tokudome T, Okumura H, Yoshihara F, Suga S, Satoshi T, Kawano Y, and Kangawa K Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts Regul Pept 124 2005 65 72 (Pubitemid 39488342)
48. K. Huynh, J.R. McMullen, T.L. Julius, J.W. Tan, J.E. Love, N. Cemerlang, H. Kiriazis, X.J. Du, and R.H. Ritchie Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy Diabetes 59 2010 1512 1520
49. Aronson D Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes J Hypertens 21 2003 3 12 (Pubitemid 36143498)
50. Asif M, Egan J, Vasan S, Jyothirmayi GN, Masurekar MR, Lopez S, Williams C, Torres RL, Wagle D, Ulrich P, Cerami A, Brines M, and Regan TJ An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness Proc Natl Acad Sci 97 2000 2809 2813 (Pubitemid 30159253)
51. Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, and Woodiwiss AJ Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats Circulation 96 1997 1991 1998 (Pubitemid 27400763)
52. Willems L, Zatta A, Holmgren K, Ashton KJ, and Headrick JP Age-related changes in ischemic tolerance in male and female mouse hearts J Mol Cell Cardiol 38 2005 245 256 (Pubitemid 40215194)
53. Budas GR, Sukhodub A, Alessi DR, and Jovanovic A 3′ Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium FASEB J 20 2006 2556 2558
54. Ban K, Cooper AJ, Samuel S, Bhatti A, Patel M, Izumo S, Penninger JM, Backx PH, Oudit GY, and Tsushima RG Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning Circ Res 103 2008 643 653